Back

DORA and LP

Official Title

Effect of a Dual Orexin Receptor Antagonist on Alzheimer's Disease Biomarkers

Study Details

The purpose of the study is to see if an investigational treatment will decrease proteins in the body that are associated with Alzheimer's.

Principal Investigator

Dr. Brendan Lucey

IRB Number

202301150

Eligibility

1. Participants must be at least 65 years old
2. Participants must not have sleep disorders
3. Participants must not have a history of stroke

Compensation is provided (contact the study team for compensation amount).

Volunteer Information

For more information about this study, contact Volunteer for Health at:

Back